Page 1 of 7
- Toll Free: +1-800-792-5285
- (UK): +44-845-528-1300
- Int'l: +1-503-894-6022
- Help@alliedmarketresearch.com
Cart
Global pharmaceutical industry completely relies on research and development to expand its offerings among consumers. Continuous development of drug compounds, discovery of new ones, and establishment of most effective routes for drug delivery after intensive clinical trials are crucial. Allied Market Research presents a compilation of reports, which offers a quantitative analysis of growth indicative figures, and extensively define each sub-segment of the market. These furnish our clients an insider’s approach to the industry, and assist stakeholders in forming investment strategies.
Page 1 of 7
The global immune checkpoint inhibitors market was valued at $10,566 million in 2017, and is projected to reach $56,530 million by 2025, registering a CAGR of 20.1% from 2018 to 2025.
The global PEGylated protein therapeutics market was valued at $10,388 million in 2017, and is estimated to reach at $17,813 million by 2025, registering a CAGR of 6.9% from 2018 to 2025.
The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.
The global occupational medicines market was valued at $3,753 million in 2017, and is estimated to reach $5,794 million by 2025, registering a CAGR of 5.5% from 2018 to 2025. Occupational medicine is a branch of clinical medicine that specializes ...
The global biopharmaceuticals market accounted for $186,470 million in 2017, and is projected to reach $526,008 million by 2025, registering a CAGR of 13.8% from 2018 to 2025. Biopharmaceuticals are substances that are produced using living organisms, such as microorganisms ...
The global benign prostatic hyperplasia therapeutics market was valued at $10,688.72 million in 2017, and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025. Benign prostatic hyperplasia (BPH) is a medical condition ...
Thyroid Gland Disorder Treatment Market is an endocrine gland that stimulates hormones, which help regulate the metabolism of the body. When the thyroid gland does not produce enough thyroid hormones (hypothyroidism) or too much hormone (hyperthyroidism), the metabolism and functioning ...
The global empty capsules market was valued at $1,841.5 million in 2017 and is expected to reach $3,707.5 million by 2025, registering a CAGR of 9.1% from 2018 to 2025. Capsules are relatively stable shells that contain or encapsulate medicines, ...
The global non-alcoholic steatohepatitis (NASH) market generated $1,179 million in 2017, and is projected to reach $21,478 million by 2025, growing at a CAGR of 58.4% from 2021 to 2025. Nonalcoholic steatohepatitis is a form of liver disease that develops ...
The Global Topical Pain Relief Market was valued at $7,481 million in 2017, and is projected to reach $13,276 million by 2025 at a CAGR of 7.4% from 2018 to 2025. Pain is a distressing feeling which is usually caused ...
The Global Acne Medication Market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025 at a CAGR of 3.9% from 2018 to 2025. Acne is a long-term skin disease that appears because of ...
The Global Cancer Therapeutics Market was valued at $81,291 million in 2016 and is estimated to reach at $178,863 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.
Regenerative medicines are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process. These medicines restore the functionality of cells & tissues and are used in several degenerative disorders such as dermatology, neurodegenerative ...
The Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of 7.9% from 2018 to 2024. In terms of volume, the market garnered ...
The global aneurysmal subarachnoid hemorrhage drugs market was valued at $160,269 thousand in 2016, and is estimated to reach $206,675 thousand by 2023, growing at a CAGR of 3.6% from 2017 to 2023. Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening ...
The global cognitive and memory enhancer drugs market was valued at $3,680 million in 2016, and is projected to reach $6,598 million by 2023, growing at a CAGR of 8.6% from 2017 to 2023. Cognitive enhancers are drugs and supplements, ...
Genes are composed of DNA that contains necessary information for making proteins that are vital for the human body to function optimally. Some gene mutations result in these proteins not being made correctly and can lead to genetic disorders. Gene ...
Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every ...
The India IVF Services Market was valued at $256.0 million in 2016, and is estimated to reach $829.5 million by 2023, registering a CAGR of 18.2% from 2017-2023. The India IVF services market is developing steadily and is projected to ...
Gynecological Cancer Drugs Market size was valued at $9,269 million in 2016, and is expected to reach $16,107 million by 2023, growing at a CAGR of 8.1% from 2017 to 2023.
3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, as a result of ...
The global cephalosporin market was valued at $77,764 million in 2016, and is estimated to reach $1,99,754 million by 2023, growing at a CAGR of 14.4% from 2017 to 2023. Cephalosporin is a bactericidal β-lactam antibiotic, which is used to ...
The Global Gastroparesis Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis is a medical condition of the stomach, which affects the normal spontaneous ...
Global Ophthalmic Drugs Market size was valued at $29,613 million in 2016, and is expected to reach $42,663 million by 2023, registering a CAGR of 5.3% from 2017 to 2023. Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic ...
Global Protein Therapeutics Market accounted for $140,109 million in 2016, and is anticipated to reach $217,591 million by 2023, registering a CAGR of 6.5% from 2017 to 2023. Therapeutic protein drugs are an important class of medicines, which are administered ...
The Global Pain Management Drugs Market is estimated to reach from $58,577 million in 2016, $77,131 million by 2023. It is anticipated to register a CAGR of 4% during the forecast period, 2017-2023. Pain is a distressing sensory and emotional ...
The global BCG vaccine market was valued at $20,366 thousands in 2016, and is estimated to reach $28,051 thousands by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Bacillus Calmette“Guérin (BCG) vaccine is the only vaccine currently ...
Ulcerative Colitis (UC) is a chronic, debilitating disease that affects large intestine or colon. The cause of ulcerative colitis is unknown however, researchers believe that it is an exaggerated immune response to a microbial trigger. UC is characterized by inflammation ...
Antibody Drug Conjugates Market are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. ADC™s are designed to eliminate cancer cells only without harming the normal cells. This is a major advantage of ADC™s as the unharmed ...
The global diabetes therapeutics market was valued at $66,993 million in 2016, and is estimated to reach $186,842 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. Diabetes therapeutics are drugs used by diabetics to maintain the blood glucose levels to restore the blood glucose metabolism to a normal state.
global over the counter (OTC) drugs & dietary supplements market was valued at $223 billion in 2016, and is expected to reach $335 billion by 2023, registering a CAGR of 5.9% from 2017 to 2023. OTC drugs are also known ...
global nanomedicine market accounted for $111,912 million in 2016, and is anticipated to reach $261,063 million by 2023, registering a CAGR of 12.6% from 2017 to 2023. Nanomedicine is one of the applications of nanotechnology used in diagnosis, treatment, monitoring, ...
global immunoglobulin was valued at $8,374 million in 2016, and is projected to reach $13,619 million by 2023, registering a CAGR of 7.3% from 2017 to 2023. Immunoglobulin is a protein produced by plasma cells and other lymphocytes. They are ...
Global Cancer Vaccines Market is expected to reach at $12,814 million from $4,073 million and register a CAGR of 17.7%, during the forecast period, 2017 - 2023.
Global Antifungal Drugs Market is expected to rise from $13,719 million in 2016 to $17,718 million by 2023. The industry is anticipated to register a CAGR of 3.7%, during the forecast period, 2017“ 2023. The antifungal drugs detect and eliminate ...
Global Potential Analysis of Human DNA Vaccines Market is expected to account for $3,762 million in 2020 and reach $9,337 million by 2030, by growing at a CAGR of 9.5% during the period, 2020 - 2030.
Malaysia IVIG Market is estimated to reach at $18,649 million from $12,277 thousand and register a CAGR of 6.1% during the period, 2016“ 2022. IVIG is a blood derived product formulated from the serum of between ~10, 000 donors per ...
Global Vaccines Market was valued at $31,216 million in 2016, and is expected to reach $65,148 million in 2023, and register a CAGR of 10.9%, during the forecast period, 2017“ 2023. Vaccine is a biological preparation that is administered to ...
Global Orphan Drugs Market is expected to garner $169 billion from $106 billion and register a CAGR of 6.8% during the forecast period, 2016“2022. Orphan drug can be defined as a pharmaceutical agent specifically designed to treat rare (orphaned) diseases. ...
Global Animal Vaccines Market is expected to garner $9,159 million, registering a CAGR of 5.2% during the forecast period, 2016-2022. Animal vaccines control the transmission diseases, thus providing protection to animal and human health. Animals serve as an important source ...
Global Male Hypogonadism Market is estimated to reach $3,233 million from $2,594 million and is supported by a CAGR of 3.1% during the forecast period. Male hypogonadism is a medical condition in which testes cannot produce enough testosterone, resulting in ...
Global HIV Drug Market was valued at $20,448 million in 2015 and is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the forecast period 2016-2022. Human immunodeficiency virus (HIV) is one of the most infectious ...
The global chemotherapy-induced Nausea and Vomiting (CINV) market was valued at $1,663 million in 2015, and is estimated to reach $2,659 million by 2022, registering a CAGR of 7.1% during the forecast period 2016-2022. Nausea and vomiting (emesis) caused by cancer ...
The global phytosterols market size is expected to reach $935 million by 2022 from $490 million in 2015 at a CAGR of 9.62% from 2016 to 2022. The phytosterols market holds substantial scope for growth globally. Its contribution to the ...
The Zika virus vaccines market is estimated to reach $18,697 million by 2022 from $14,500 million in 2017. The Zika virus vaccines market growth rate is 5.2% during the forecast period. Zika virus infection is a mosquito-borne illness transmitted through Aedes genus same as other mosquito-borne illness such as japanese encephalitis virus, West Nile viruses, and yellow fever virus.
The global netupitant“palonosetron FDC market accounted for $257,162 million in 2015, and is estimated to reach $527,187 million by 2022, growing at a CAGR of 10.8% during the forecast period. The netupitant“palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors.
Global pharmaceuticals packaging market is expected to reach $104,882 million by 2022 from $68,749 million in 2015, growing at a CAGR of 6.27% from 2016 to 2022. This market is expected to witness notable growth in the coming years, owing ...
IVIG market (Intravenous Immunoglobulin Market) was valued at $7,861 million, and is expected to reach $12,632 million by 2022, supported by a CAGR of 7.1%. Immunoglobulins (IGs) are glycoproteins produced in the blood plasma in response to the antigens, which are foreign to the host system.
Asthma and COPD (Chronic Obstructive Pulmonary Disease) are chronic diseases characterized by airway obstruction in the lungs causing respiratory infection and fatigue. COPD is characterized by yellow phlegm in the cough and episodes of cough and wheezing at night are ...
Global Liver Disease Treatment Market is expected to garner $19,536 million by 2022, registering a CAGR of 11.72% during the forecast period 2016-2022. Liver disease comprises of wide range of complex conditions affecting the liver. Liver disease treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications.
Page 1 of 7
To ensure high level data integrity, accurate analysis and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
